Page last updated: 2024-11-11

cholesteryl arachidonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cholesteryl arachidonate: RN given refers to (3beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cholesteryl arachidonate : A cholesterol ester obtained by the formal condensation of the hydroxy group in cholesterol with the carboxy group of arachidonic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6479222
CHEBI ID82751
MeSH IDM0093715

Synonyms (28)

Synonym
604-34-2
cholest-5-en-3-ol (3beta)-, 5,8,11,14-eicosatetraenoate, (all-z)-
cholesterol arachidonate
[(3s,8s,9s,10r,13r,14s,17r)-17-[(1r)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] (5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoate
cholesteryl arachidonate
ce(20:4)
LMST01020014
20:4 cholesteryl ester
cholest-5-en-3beta-yl (5z,8z,11z,14z-eicosatetraenoate)
[(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] (5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoate
(3beta)-cholest-5-en-3-yl (5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoate
cholest-5-en-3beta-yl (5z,8z,11z,14z-icosatetraenoate)
ce(20:4(5z,8z,11z,14z))
CHEBI:82751
cholesteryl (5z,8z,11z,14z-eicosatetraenoate)
3beta-hydroxy-5-cholestene 3-arachidonate
HY-113369
Q27156282
CS-0062307
DTXSID701313431
(1r,3as,3bs,7s,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-yl (5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoate
AS-83106
AKOS040732814
cholesterol 5z,8z,11z,14z-eicosatetraenoic acid ester
cholest-5-en-3-ol (3beta)-, (5z,8z,11z,14z)-5,8,11,14-eicosatetraenoate
arachidonic acid, cholesteryl ester
USB7VS82GH
cholest-5-en-3-ol (3beta)-, 3-[(5z,8z,11z,14z)-5,8,11,14-eicosatetraenoate]
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
cholesteryl icosatetraenoateA cholesterol ester in which the acyl group contains 20 carbons and 4 double bonds.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (33.33)18.7374
1990's6 (33.33)18.2507
2000's5 (27.78)29.6817
2010's1 (5.56)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.48 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.24 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]